|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
79,620,000 |
Market
Cap: |
12.77(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.1604 - $0.1604 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Soleno Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare diseases. Co.'s primary candidate is Diazoxide Choline Extended Release tablets (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
343,298 |
343,298 |
Total Buy Value |
$0 |
$0 |
$1,897,756 |
$1,897,756 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
12 |
12 |
Total Shares Sold |
28,591 |
318,615 |
318,615 |
929,209 |
Total Sell Value |
$1,181,970 |
$10,773,060 |
$10,773,060 |
$11,735,467 |
Total People Sold |
4 |
4 |
4 |
5 |
Total Sell Transactions |
4 |
25 |
25 |
74 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Anish Bhatnagar |
CHIEF EXECUTIVE OFFICER |
|
2024-04-01 |
4 |
S |
$41.12 |
$784,645 |
D/D |
(18,980) |
152,790 |
|
- |
|
Yen Kristen |
SEE REMARKS |
|
2024-04-01 |
4 |
S |
$41.12 |
$91,694 |
D/D |
(2,218) |
23,422 |
|
- |
|
Hirano Patricia C |
SEE REMARKS |
|
2024-04-01 |
4 |
S |
$41.12 |
$91,694 |
D/D |
(2,218) |
50,924 |
|
- |
|
Mackaness James H |
CHIEF FINANCIAL OFFICER |
|
2024-04-01 |
4 |
S |
$41.12 |
$213,937 |
D/D |
(5,175) |
62,953 |
|
- |
|
Yen Kristen |
SEE REMARKS |
|
2024-01-25 |
4 |
S |
$48.30 |
$19,175 |
D/D |
(397) |
25,640 |
|
- |
|
Hirano Patricia C |
SEE REMARKS |
|
2024-01-25 |
4 |
S |
$48.30 |
$40,186 |
D/D |
(832) |
43,142 |
|
- |
|
Anish Bhatnagar |
CHIEF EXECUTIVE OFFICER |
|
2024-01-25 |
4 |
S |
$48.30 |
$122,054 |
D/D |
(2,527) |
171,770 |
|
- |
|
Mario Ernest |
Director |
|
2024-01-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,523 |
124,566 |
|
- |
|
Hirano Patricia C |
See Remarks |
|
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
43,974 |
|
- |
|
Mackaness James H |
Chief Financial Officer |
|
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
56,000 |
68,128 |
|
- |
|
Anish Bhatnagar |
Chief Executive Officer |
|
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
174,297 |
|
- |
|
Yen Kristen |
See Remarks |
|
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
26,037 |
|
- |
|
Hirano Patricia C |
See Remarks |
|
2023-12-14 |
4 |
S |
$36.49 |
$49,584 |
D/D |
(1,359) |
19,974 |
|
- |
|
Hirano Patricia C |
See Remarks |
|
2023-12-13 |
4 |
S |
$38.79 |
$189,513 |
D/D |
(4,885) |
21,333 |
|
- |
|
Yen Kristen |
See Remarks |
|
2023-12-13 |
4 |
S |
$37.76 |
$676,557 |
D/D |
(17,916) |
2,037 |
|
- |
|
Yen Kristen |
See Remarks |
|
2023-12-13 |
4 |
OE |
$2.41 |
$45,644 |
D/D |
17,916 |
19,953 |
|
- |
|
Yen Kristen |
See Remarks |
|
2023-12-12 |
4 |
S |
$36.64 |
$735,874 |
D/D |
(19,913) |
2,037 |
|
- |
|
Mackaness James H |
Chief Financial Officer |
|
2023-12-11 |
4 |
S |
$35.49 |
$1,182,828 |
D/D |
(32,482) |
12,128 |
|
- |
|
Mackaness James H |
Chief Financial Officer |
|
2023-12-11 |
4 |
OE |
$2.60 |
$38,925 |
D/D |
15,000 |
44,610 |
|
- |
|
Anish Bhatnagar |
Chief Executive Officer |
|
2023-12-11 |
4 |
S |
$35.26 |
$3,331,701 |
D/D |
(93,408) |
24,297 |
|
- |
|
Yen Kristen |
See Remarks |
|
2023-11-30 |
4 |
S |
$28.65 |
$113,547 |
D/D |
(3,963) |
21,950 |
|
- |
|
Mario Ernest |
Director |
|
2023-11-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,700 |
128,089 |
|
- |
|
Mackaness James H |
Chief Financial Officer |
|
2023-11-30 |
4 |
S |
$28.65 |
$119,937 |
D/D |
(4,186) |
21,303 |
|
- |
|
Anish Bhatnagar |
Chief Executive Officer |
|
2023-11-30 |
4 |
S |
$28.65 |
$794,116 |
D/D |
(27,716) |
108,062 |
|
- |
|
Hirano Patricia C |
See Remarks |
|
2023-11-30 |
4 |
S |
$28.65 |
$109,536 |
D/D |
(3,823) |
26,218 |
|
- |
|
386 Records found
|
|
Page 1 of 16 |
|
|